|Mr. Gene S. Cartwright Ph.D.||Chief Exec. Officer, Pres, Acting Chief Financial Officer and Director||254.99k||N/A||1954|
|Dr. Mark L. Faupel Ph.D.||Chief Operating Officer and Director||132.56k||N/A||1955|
|Mr. Richard L. Fowler||Sr. VP of Engineering and Sec.||130k||N/A||1956|
|Mr. Charles Rufai||Controller||N/A||N/A||N/A|
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. It is also developing a non-invasive esophageal cancer detection product using its biophotonic technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.
Guided Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.